New book urges use of antidepressants to treat and prevent cancer.
“Killing Cancer” by Dr. Julian Lieb reviews the medical literature in showing that antidepressants have remarkable
anticancer properties.
BURLINGTON, Vt.
More than 120 clinical, laboratory and epidemiological studies support the anticancer properties of antidepressants.
Antidepressants kill cancer cells, inhibit their division, protect nonmalignant cells from damage by ionizing radiation
and chemotherapy toxicity, and convert multidrug resistant cells to sensitive. Depression significantly increases the
risk of cancer, and increases and accelerates its mortality. Antidepressants are capable of arresting cancer even in
advanced stages, and occasionally eradicating it. Studies show that antidepressants are potentially effective for many
malignancies, including some notoriously resistant to chemotherapy and radiation. Antidepressants can alleviate pain,
alone or in potentiating opiates, and many side effects of chemotherapy.
Lieb points out that the use of relatively inexpensive antidepressants could make cancer treatment available to
low-income and disadvantaged segments of the population. By slashing the cost of cancer care, antidepressants could
energize health reform, stabilize Medicare, and help to reduce the deficit.
In making the case for antidepressants, Lieb discusses prostaglandins, molecules that regulate the physiology of every
cell in the body. When produced above a critical threshold, prostaglandins cause many disorders, including depression
and cancer. By inhibiting the production of prostaglandins, antidepressants can neutralize or defeat cancer. Cancer is
not a hundred different diseases, as touted, but one disease with innumerable variations.
Every patient, physician and citizen has the human and ethical right to evaluate a new treatment approach for
themselves, without interference by any third party. They may exercise that right by accessing Pubmed or other
biomedical database.
“Killing Cancer” is available for sale online at Amazon.com and other channels.
About the Author
Dr. Julian Lieb is a retired Yale School of Medicine professor, and author or co-author of 48 articles and 11 books. He
is a recognized expert on the immunostimulating and antimicrobial properties of lithium and antidepressants, and the
anticancer properties of antidepressants. He has worked closely with pioneers in prostaglandin research, and invited to
address international cancer conferences in Greece, Germany and India.